Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$1.74 - $3.16 $64,051 - $116,322
36,811 Added 25.44%
181,525 $473,000
Q4 2023

Feb 13, 2024

BUY
$1.42 - $1.96 $189,951 - $262,187
133,769 Added 1222.19%
144,714 $253,000
Q3 2023

Nov 13, 2023

BUY
$1.42 - $1.84 $15,541 - $20,138
10,945 New
10,945 $17,000
Q1 2023

May 15, 2023

SELL
$1.85 - $2.71 $16,563 - $24,262
-8,953 Reduced 16.96%
43,826 $89,000
Q4 2022

Feb 14, 2023

BUY
$1.55 - $2.38 $20,870 - $32,046
13,465 Added 34.25%
52,779 $109,000
Q3 2022

Nov 14, 2022

SELL
$1.75 - $2.62 $13,084 - $19,589
-7,477 Reduced 15.98%
39,314 $71,000
Q2 2022

Aug 15, 2022

BUY
$1.75 - $3.71 $81,884 - $173,594
46,791 New
46,791 $86,000

Others Institutions Holding STXS

About Stereotaxis, Inc.


  • Ticker STXS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,790,096
  • Market Cap $181M
  • Description
  • Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...
More about STXS
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.